Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alina M Allen

Showing results (21-30 of 116) with videos related to

Pageof 12
Sort By:
Hepatology (Baltimore, Md.)|July 21, 2015
Comparative effectiveness of pharmacological interventions for nonalcoholic steatohepatitis: A systematic review and network meta-analysisSiddharth Singh, Rohan Khera, Alina M Allen, et al.
Hepatology (Baltimore, Md.)|April 17, 2023
It is time to expand the fatty liver disease community of practiceJeffrey V Lazarus, Christopher J Kopka, Zobair M Younossi, et al.
Nature Medicine|March 9, 2023
Challenges and opportunities in NASH drug developmentStephen A Harrison, Alina M Allen, Julie Dubourg, et al.
Hepatology (Baltimore, Md.)|August 5, 2017
Sarcopenia in hiding: The risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitisRahima A Bhanji, Praveena Narayanan, Alina M Allen, et al.
Hepatology (Baltimore, Md.)|June 6, 2021
Familial Hypobetalipoproteinemia: An Underrecognized Cause of Lean NASHSeth Buryska, Joseph C Ahn, Alina M Allen, et al.
Hepatology (Baltimore, Md.)|August 22, 2022
Performance of American Gastroenterological Association Clinical Care Pathway for the risk stratification of patients with nonalcoholic fatty liver disease in the US populationProwpanga Udompap, Terry M Therneau, Rachel E Canning, et al.
Gastroenterology|November 10, 2023
Nonalcoholic Fatty Liver Disease Gets Renamed as Metabolic Dysfunction-Associated Steatotic Liver Disease: Progress But With ChallengesAlina M Allen, Elisa Pose, K Rajender Reddy, et al.
Advances in Medical Education and Practice|May 12, 2025
Gaps in MASLD/MASH Education: A Quantitative and Qualitative Survey with Leaders of US Graduate Medical Education ProgramsAlina M Allen, Anthony R Hoovler, Amy Articolo, et al.
Gastroenterology|February 5, 2025
Liver Health: An Emerging ConceptPere Ginès, Indra Neil Guha, Núria Fabrellas, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 29, 2014
Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studiesSiddharth Singh, Alina M Allen, Zhen Wang, et al.
Pageof 12

Showing results (21-30 of 116) with videos related to

Sort By:
Pageof 12
Hepatology (Baltimore, Md.)|July 21, 2015
Comparative effectiveness of pharmacological interventions for nonalcoholic steatohepatitis: A systematic review and network meta-analysisSiddharth Singh, Rohan Khera, Alina M Allen, et al.
Hepatology (Baltimore, Md.)|April 17, 2023
It is time to expand the fatty liver disease community of practiceJeffrey V Lazarus, Christopher J Kopka, Zobair M Younossi, et al.
Nature Medicine|March 9, 2023
Challenges and opportunities in NASH drug developmentStephen A Harrison, Alina M Allen, Julie Dubourg, et al.
Hepatology (Baltimore, Md.)|August 5, 2017
Sarcopenia in hiding: The risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitisRahima A Bhanji, Praveena Narayanan, Alina M Allen, et al.
Hepatology (Baltimore, Md.)|June 6, 2021
Familial Hypobetalipoproteinemia: An Underrecognized Cause of Lean NASHSeth Buryska, Joseph C Ahn, Alina M Allen, et al.
Hepatology (Baltimore, Md.)|August 22, 2022
Performance of American Gastroenterological Association Clinical Care Pathway for the risk stratification of patients with nonalcoholic fatty liver disease in the US populationProwpanga Udompap, Terry M Therneau, Rachel E Canning, et al.
Gastroenterology|November 10, 2023
Nonalcoholic Fatty Liver Disease Gets Renamed as Metabolic Dysfunction-Associated Steatotic Liver Disease: Progress But With ChallengesAlina M Allen, Elisa Pose, K Rajender Reddy, et al.
Advances in Medical Education and Practice|May 12, 2025
Gaps in MASLD/MASH Education: A Quantitative and Qualitative Survey with Leaders of US Graduate Medical Education ProgramsAlina M Allen, Anthony R Hoovler, Amy Articolo, et al.
Gastroenterology|February 5, 2025
Liver Health: An Emerging ConceptPere Ginès, Indra Neil Guha, Núria Fabrellas, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 29, 2014
Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studiesSiddharth Singh, Alina M Allen, Zhen Wang, et al.
Pageof 12